Cue Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cue Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q3 2024.
- Cue Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 51.2M shares, a 10.5% increase year-over-year.
- Cue Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 45.8M shares, a 28.3% increase from 2022.
- Cue Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 35.6M shares, a 13.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)